SCYX - SCYNEXIS INC
0.892
-0.007 -0.841%
Share volume: 305,951
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$0.90
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-08-2024 | 11-06-2024 | 03-12-2025 | 05-15-2025 | 08-13-2025 | 11-05-2025 | 03-04-2026 | |
| Cash flow financing | -15.000 K | 0.000 | 31.000 K | -155.000 K | -14.084 M | 0.000 | 29.000 K | -115.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 40.000 K | -110.000 K | 0.000 | 0.000 | 110.000 K | |
| Cash flow | -4.007 M | 0.000 | 2.737 M | -12.679 M | -9.109 M | 0.000 | 3.722 M | 6.462 M | |
| Net income | 411.000 K | -14.458 M | -2.808 M | -4.433 M | -5.391 M | -6.885 M | -8.591 M | 12.258 M | |
| Depreciation | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 5.454 M | 1.372 M | 1.941 M | -2.617 M | 12.440 M | 11.273 M | 12.417 M | -11.824 M | |
| Net Borrowings | -98.450 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 80.244 M | -9.488 M | 2.737 M | -12.679 M | -9.109 M | 3.778 M | 3.722 M | 6.462 M |